Answer
No, patients who developed pure red cell aplasia after treatment with any erythropoietin must not receive Retacrit (epoetin zeta) or any other erythropoietin.
Sources for this answer
- Retacrit 1 000 IU/0.3 mL solution for injection in pre filled syringePfizer Limited · emc · SmPC §4.3 Contraindications · Version 31Document updated
Sources checked